Potential Successor to Warren Buffett at Berkshire Faces Significant Challenges
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 31 2025
0mins
Should l Buy CVX?
Source: Barron's
Ted Weschler's Role: Ted Weschler is poised to become Berkshire Hathaway's leading stockpicker.
Investment Success: He transformed an IRA account of approximately $70,000 in the late 1980s into $221 million by 2018.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CVX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CVX
Wall Street analysts forecast CVX stock price to fall
19 Analyst Rating
15 Buy
4 Hold
0 Sell
Strong Buy
Current: 182.500
Low
158.00
Averages
176.95
High
206.00
Current: 182.500
Low
158.00
Averages
176.95
High
206.00
About CVX
Chevron Corporation is an integrated energy company. The Company produces crude oil and natural gas; manufactures transportation fuels, lubricants, petrochemicals and additives; and develops technologies that enhance its business and industry. The Company’s segments include Upstream and Downstream. Upstream operations consist primarily of exploring for, developing, producing and transporting crude oil and natural gas; liquefaction, transportation and regasification associated with LNG; transporting crude oil by major international oil export pipelines; processing, transporting, storage and marketing of natural gas; carbon capture and storage; and a gas-to-liquids plant. Downstream operations consist primarily of the refining of crude oil into petroleum products; marketing crude oil, refined products, and lubricants; manufacturing and marketing of renewable fuels, and transporting of crude oil and refined products by pipeline, marine vessel, motor equipment and rail car.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Shareholder Return History: Chevron has returned over $5 billion in capital to shareholders over the last 16 quarters, with $3.5 billion allocated to dividends, demonstrating the company's ability to consistently reward investors even in volatile markets, thereby enhancing investor confidence.
- Low Break-even Point: Chevron maintains a break-even price of $50 per barrel for Brent crude oil, thanks to investments in high-quality assets and disciplined cost management, allowing it to generate higher free cash flow in the current environment where prices are nearing $100 per barrel.
- Optimistic Market Outlook: The U.S. Energy Information Administration projects oil prices could peak at $115 per barrel in the second quarter and not fall below $90 until the fourth quarter, providing a strong tailwind for Chevron's earnings and further solidifying its position in the energy market.
- Investment in High-margin Assets: Chevron focuses on high-margin assets such as the Permian Basin and the Gulf of Mexico, successfully integrating Hess to gain a 30% stake in the Stabroek Block, ensuring future growth potential and competitive strength in the market.
See More
- Global Oil Shortage: Shell CEO Wael Sawan warns of a current shortfall of 1 billion barrels of oil, a sentiment echoed by Halliburton CEO Jeffrey Miller, indicating that this shortage will exacerbate rising oil prices and impact global economic stability.
- Consensus Among Executives: CEOs from Chevron and ExxonMobil agree that it will take months to rectify the growing supply-demand imbalance, highlighting the profound effects of current geopolitical conflicts on the oil market, which necessitates cautious investor strategies.
- Dividend Performance Discrepancy: While Shell offers a dividend yield of 3.4%, Chevron and Exxon have a stronger track record of dividend growth at 3.9% and 2.8% respectively, making them more attractive for long-term investors seeking stability.
- Investment Strategy Recommendation: For long-term investors, Chevron is viewed as the most appealing option among integrated energy giants, particularly as oil prices are expected to decline, providing reliable dividend income and mitigating investment risks.
See More
- Global Oil Shortage: The closure of the Strait of Hormuz due to the Middle East conflict has resulted in a shortage of 1 billion barrels of oil, with Shell CEO Wael Sawan and Halliburton CEO Jeffrey Miller sounding alarms about the ongoing supply/demand imbalance that is expected to last for months, impacting global energy market stability.
- Industry Response: CEOs of Chevron and ExxonMobil concur that it will take months to rectify the supply/demand imbalance once the conflict ends, indicating that the oil supply shortfall will worsen in the interim, potentially leading to increased volatility in oil prices.
- Investment Strategy: In the current high oil price environment, investors are advised to focus on integrated energy giants like Shell, Chevron, and Exxon, noting that while Shell cut its dividend in 2020, Chevron and Exxon have consistently increased theirs, demonstrating stronger financial stability.
- Dividend Yield Comparison: Currently, Chevron offers a dividend yield of 3.9%, Exxon at 2.8%, and Shell at 3.4%, making Chevron the most attractive option among integrated majors for long-term investors, especially as oil prices are expected to decline, providing reliable dividend income.
See More
- Global Oil Shortage: Shell CEO Wael Sawan warns that the world is currently short 1 billion barrels of oil, a sentiment echoed by Halliburton CEO Jeffrey Miller, indicating a growing supply crisis that threatens global energy market stability.
- Ongoing Conflict Impact: CEOs from Chevron and ExxonMobil agree that it will take months to rectify the supply/demand imbalance, suggesting that until the Middle East conflict is resolved, oil supply shortages will persist, potentially leading to increased price volatility.
- Dividend Performance Comparison: While Shell offers a 3.4% dividend yield, Chevron and Exxon have a stronger track record of dividend growth, with Chevron at 3.9% and Exxon at 2.8%, making them more attractive to investors, especially during periods of low oil prices.
- Investment Recommendations: Analysts suggest that given Chevron and Exxon's robust balance sheets and consistent dividend growth, long-term investors in the energy sector may prefer these companies over Shell, which faces greater investment risks.
See More
- Investment Moves: Buffett's new position in the New York Times, valued at $351 million, indicates a strategic shift from tech stocks to traditional sectors, potentially altering the overall risk profile of his investment portfolio.
- Digital Subscription Growth: The New York Times added 450,000 digital subscribers in the last quarter, bringing the total to approximately 12.8 million, demonstrating significant progress in its digital transformation and potential for future revenue enhancement.
- Advertising Revenue Surprises: Digital advertising revenue surged to 25%, exceeding expectations of high teens, indicating strengthened competitiveness in the advertising market, which may support future profitability.
- Valuation Concerns: Despite generating $550 million in free cash flow, the New York Times' market cap is nearly $12 billion, resulting in a free cash flow yield of only 4.6%, raising concerns about its valuation and potentially limiting further stock price appreciation.
See More
- New Position: On May 8, 2026, ACT Capital Management disclosed a new position in Alumis by acquiring 174,250 shares valued at approximately $4.36 million, indicating strong confidence in the company's future prospects.
- Quarterly Valuation: The position's valuation stood at $3.84 million at quarter-end, reflecting the impact of market price changes and share count, highlighting Alumis's significance in the investment portfolio.
- Stock Performance: Alumis shares surged 350% over the past year, significantly outperforming the S&P 500's 30% gain, showcasing its robust growth potential in the biopharmaceutical sector.
- Clinical Progress: Alumis reported positive Phase 3 data for moderate-to-severe plaque psoriasis in March, with plans to submit a New Drug Application in the second half of 2026, further boosting investor confidence in its drug development pipeline.
See More











